RegeneRx and G-treeBNT partner to develop RGN-259 in the U.S. for ophthalmic indications Jan. 29, 2015 No Comments
Envisia Therapeutics begins phase IIa trial of ENV-515 in patients with glaucoma Jan. 29, 2015 No Comments
Isarna files to begin clinical studies of ISTH-0036 for ophthalmic diseases Jan. 13, 2015 No Comments
Biogen Idec discloses phase II trial results for BIIB-033 in acute optic neuritis Jan. 12, 2015 No Comments
RSS